| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 05/12/2005 | US20050101644 Benzylether amine compounds useful as CCR-5 antagonists |
| 05/12/2005 | US20050101641 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 05/12/2005 | US20050101626 Imidazo-fused oxazolo[4,5-beta]pyridine and imidazo-fused thiazolo[4,5-beta]pyridine based tricyclic compounds and pharmaceutical compositions comprising same |
| 05/12/2005 | US20050101596 Such as N,N-dimethyl-3-(phenylsulfonyl)-6,7,8,9-tetrahydro-3H-benzo[e]indol-8-amine; for treatment of central nervous system disorders related to or affected by serotonin receptor antagonists such as neurodegenerative disorders, attention deficit disorder, obsessive compulsive disorder, and drug abuse |
| 05/12/2005 | US20050101595 N-containing cycloalkyl-substituted amino-thiazole derivatives and pharmaceutical compositions for inhibiting cell proliferation and methods for their use |
| 05/12/2005 | US20050101592 3-(4-chlorophenyl)-2-(2-chlorophenyl)-7-(2,2,2-trifluoroethyl)-6,7-dihydro-2H,5H-4-oxa-1,2,7-triaza-azulen-8-one; for treatment of disorders linked to mediation of cannabinoid receptors |
| 05/12/2005 | CA2544357A1 Tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same |
| 05/12/2005 | CA2544348A1 Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same |
| 05/12/2005 | CA2543436A1 Spirofuropyridine aryl derivatives |
| 05/12/2005 | CA2542047A1 Hydroxy pyridopyrrolopyrazine dione compounds useful as hiv integrase inhibitors |
| 05/11/2005 | EP1363899B1 Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists |
| 05/11/2005 | EP0971898B1 Substituted isoquinolines as ultra short acting neuromuscular blockers |
| 05/11/2005 | CN1615311A 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide |
| 05/11/2005 | CN1200609C Substituted aminomethyl phenyl sulphonyl ureas, their production and their use as herbicides and plant growth regulators |
| 05/10/2005 | US6890943 3-acylated pyridoxal derivatives used to treat vitamin B6 deficiency, cardiovascular diseases, melanoma and other related diseases |
| 05/10/2005 | US6890928 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 05/10/2005 | US6890922 For treatment of erectile dysfunction as well as female sexual dysfunction, incontinence, and hypertrophy of the prostate; inhibitors of cGMP-metabolizing phosphodiesterases (cGMP= cyclic guanosine monophosphate) |
| 05/10/2005 | US6890915 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE) |
| 05/10/2005 | CA2191815C Heterocyclic compounds having tachykinin receptor antagonist activity, their preparation and their use |
| 05/06/2005 | WO2005039484A2 Indolocarbazole anticancer agents and methods of using same |
| 05/06/2005 | WO2004113394A3 Living radical polymerization initiator comprising a functional group capable of reacting with polypeptides or the like, comb polymer obtained therewith, polypeptide conjugates and drugs obtained therefrom |
| 05/05/2005 | US20050096467 Blue 3H-naphtho[2,1-b]pyran compounds and use thereof in photochromic articles |
| 05/05/2005 | US20050096347 Beta3-Adrenoreceptor agonists, agonist compositions and methods of using |
| 05/05/2005 | US20050096341 Novel tiotropium salts, process for the preparation and pharmaceutical compositions thereof |
| 05/05/2005 | US20050096340 lipophilic derivatives of paclitaxel, camptothecin, docetaxel or derivatives thereof; tocopherol succinate paclitaxel for example; emulsions for drug delivery, treating cancer; increased plasma elimination half-life compared to the parent therapeutic drug |
| 05/05/2005 | US20050096338 Camptothecin analogs having an E-ring ketone |
| 05/04/2005 | EP1528062A2 Process for the preparation of s-type 4-substituted hydroxypyranoindolidine compounds |
| 05/04/2005 | EP1528061A1 Heterocyclic derivatives which inhibit factor Xa |
| 05/04/2005 | EP1527070A1 Azole methylidene cyanide derivatives and their use as protein kinase modulators |
| 05/04/2005 | EP1527053A1 Process for preparing rizatriptan |
| 05/04/2005 | EP1411881B1 5ht2c receptor modulators |
| 05/04/2005 | EP1317448B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/04/2005 | CN1611505A Novel 9-nitro campotothecin crystal form and medicinal composition |
| 05/04/2005 | CN1611504A Method for separating lycorine from plant extract |
| 05/04/2005 | CN1611503A Method for separating lycoramine from plant extract |
| 05/04/2005 | CN1611502A Method for separating galanthamine from plant extract |
| 05/04/2005 | CN1199974C Spiro (2H-1-benzopyran-2,4'-piperididine) derivates as glycine transport inhibitors |
| 05/03/2005 | US6887998 Process for 8-carboxamido-2,6-methano-3-benzazocines |
| 05/03/2005 | US6887892 Tricyclic derivatives of indole with antiangiogenic activity |
| 05/03/2005 | US6887882 Comprises (5bR-(5b-a,6b,12b-a))-5b,6,7,12b,13,14-hexahydro-13 -methyl(1,3)benzodioxolo(5,6c)-1,3-dioxolo(4,5-i)phenanthrid in-6-ol; for use as antiarrhythmic drugs; potassium channel modulators |
| 05/03/2005 | CA2157234C Stereoselective process for producing dihydro-2-3-benzodiazepine derivatives |
| 04/28/2005 | WO2005037843A1 Compositions useful as inhibitors of protein kinases |
| 04/28/2005 | WO2005037839A1 Norcantharidin derivative compounds, method for the production thereof, compositions containing said compounds and the use thereof |
| 04/28/2005 | WO2005037825A2 Protein kinase inhibitors |
| 04/28/2005 | WO2005037796A1 Compounds and methods for treating dyslipidemia |
| 04/28/2005 | WO2005014517A3 Novel dibenzo[b,f]oxepine-10-carboxamides and pharmaceutical uses thereof |
| 04/28/2005 | WO2004100888A3 N-thiolated azetidinones and anti-cancer use thereof |
| 04/28/2005 | WO2004094367A3 A process for the stereoselective synthesis of lactones |
| 04/28/2005 | WO2004065539A3 Androgen receptor antagonists |
| 04/28/2005 | US20050090533 Treating schizophrenia by administering an N-(2-aminopyridin-5-yl)amino-phenylisobutyramide, e.g., N-[6-(2-acetylamino-ethylamino)-4-(2-chloro-phenyl)-pyridin-3-yl]-2-(3,5-bis-trifluoromethyl-phenyl)-N-methyl-isobutyramide |
| 04/28/2005 | US20050090526 3-Cyano-7-methoxy-4-(3-bromo-4,5-dimethoxyphenyl)-2-oxo-2H-chromene; 7-Amino-4-(3-bromo-4,5-dimethoxy-phenyl)-3-cyano-2-imino-2H-chromene; anticancer, antitumor agent |
| 04/28/2005 | US20050090521 Tetrazoloquinoline, triazoloquinoline, and oxazoloquinoline compounds, e.g., 9-chloro-N-isopropoxytetrazolo[1,5-a]quinoline-4-carboxamide |
| 04/28/2005 | US20050090519 1-Alkyl-4-(3-substitutedphenyl)piperidines |
| 04/28/2005 | US20050090498 3-Quinolin-2(1h)-ylideneindolin-2-one derivative |
| 04/28/2005 | US20050090484 Purification of natural, synthetic or semi-synthetic crude harringtonines by reverse phase chromatography and crystallization; solvent is water or lower alkanol, or an aqueous mixture of organic solvents; enantiomerically pure; industrial scale; leukemia chemotherapy |
| 04/28/2005 | US20050090431 Water soluble prodrugs of hindered alcohols |
| 04/28/2005 | US20050090400 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide |
| 04/28/2005 | US20050089713 Organic electroluminescent element |
| 04/28/2005 | CA2542113A1 Compositions useful as inhibitors of protein kinases |
| 04/28/2005 | CA2542076A1 Substituted tricyclic compounds as protein kinase inhibitors |
| 04/27/2005 | EP1526133A1 Epothilone derivatives |
| 04/27/2005 | EP1526130A1 Substituted isoquinolines as ultra short acting neuromuscular blockers |
| 04/27/2005 | EP1525265A2 Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups |
| 04/27/2005 | EP1524974A2 Transcription factor modulating compounds and methods of use thereof |
| 04/27/2005 | EP1040098B1 Integrin receptor antagonists |
| 04/27/2005 | EP0968181B1 Perfluorynated sulphone salts, and their uses as ionic conduction materials |
| 04/27/2005 | EP0942733B1 Use of nk-1 receptor antagonists for treating cognitive disorders |
| 04/27/2005 | EP0741569B1 Naphthylisoquinoline alkaloids, pharmaceutical compositions containing them and their use for the treatment of malaria |
| 04/27/2005 | CN1610681A Polycyclic compounds having anti-tumor activity |
| 04/27/2005 | CN1610680A Process for preparing scopine esters |
| 04/27/2005 | CN1610677A Halogenated nitrobutadienes for controlling animal pests |
| 04/27/2005 | CN1610551A Parenteral administration of 6-hydroxy-oxymorphone for use as an analgesic |
| 04/27/2005 | CN1610546A 病毒聚合酶抑制剂 Viral polymerase inhibitor |
| 04/27/2005 | CN1198851C N-alkoxy-4,4-dioxy-polyalkyl-piperidine compounds, their corresponding N-oxides and controlled radical polymerization therewith |
| 04/27/2005 | CN1198834C Water soluble produgs of hindered alcohols or phenols |
| 04/27/2005 | CN1198823C Phenyl substituted 4-hydroxy tetrahydropyridone |
| 04/26/2005 | US6885026 Organic element for electroluminescent devices |
| 04/26/2005 | US6884893 Selective cleavage of a cycloanhydride derivative by reacting cycloanhydride with a chiral aminoalcohol in an inert solvent to form a monoester |
| 04/26/2005 | US6884805 Polymorph forms of N-(2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-B]quinolin-4-YL)-2-(2-oxopyrrolidin-1-YL)acetamide |
| 04/26/2005 | US6884803 Phenylalkynes |
| 04/21/2005 | WO2005035613A1 Process for making amide acetals |
| 04/21/2005 | WO2005035536A1 Novel xanthone derivative, process for producing the same and pharmaceutical composition containing the same |
| 04/21/2005 | WO2005035524A1 Pyrrolidinyl urea derivatives as angiogensis inhibitors |
| 04/21/2005 | WO2005035498A1 Use of nitrogenous bicyclic compound as feeding control agent |
| 04/21/2005 | WO2005034944A1 Combinations of indole compounds and alkylating agents for the treatment of cancer |
| 04/21/2005 | WO2005004801A3 Indole, azaindole and related heterocyclic n-substituted piperazine derivatives |
| 04/21/2005 | US20050085468 Substituted quinobenzoxazine analogs |
| 04/21/2005 | US20050085467 Androgen receptor antagonists |
| 04/21/2005 | US20050085466 such as 1-[4-(2-oxo-4-trifluoromethyl-1,2-dihydroquinolin-6-ylmethyl)benzenesulfonyl]-piperidine-3-carboxylic acid ethyl ester; for treatment of acne, alopecia, and oily skin; kits |
| 04/21/2005 | US20050085465 Quinazoline compounds |
| 04/21/2005 | US20050084763 low melting electrolyte comprising salts where the anionic charge is delocalized, mixed with metallic salts, polar polymers and/or aprotic solvents |
| 04/21/2005 | US20050084451 Novel chelating agents and chelates and their use |
| 04/21/2005 | CA2541086A1 Process for making amide acetals |
| 04/21/2005 | CA2540868A1 Pyrrolidinyl urea derivatives as angiogenesis inhibitors |
| 04/20/2005 | EP1349847B1 Oxybenzamides derivatives as factor xa inhibitors |
| 04/20/2005 | EP1213290B1 Dihydrobenzofuran derivatives, process for the preparation thereof and agents |
| 04/20/2005 | CN1608069A Selective androgen receptor modulators and methods for their identification, design and use |
| 04/20/2005 | CN1608052A Synthesis of enantiomerically pure amino-substituted fused bicyclic rings |
| 04/20/2005 | CN1197866C 4, 6-dihydrofuro [3, 4-d] imidazole-6- ketone derivative and salt and preparation method thereof |
| 04/20/2005 | CN1197859C Febrifugine and isofebrifugine and processes for the preparation of both |